Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Eli Lilly and Company
Eli Lilly and Company
Actuate Therapeutics Inc.
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Dartmouth-Hitchcock Medical Center